Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 122.95 Million USD | 1419.36% |
| 2022 | 8.08 Million USD | 562.24% |
| 2021 | -1.74 Million USD | -110.3% |
| 2020 | 16.97 Million USD | -78.19% |
| 2019 | 77.83 Million USD | 142.39% |
| 2018 | 32.11 Million USD | 36.4% |
| 2017 | 23.54 Million USD | 25.72% |
| 2016 | 18.72 Million USD | 333.82% |
| 2015 | 4.31 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.85 Million USD | 100.63% |
| 2024 Q1 | 7.82 Million USD | -93.37% |
| 2023 Q2 | 4.39 Million USD | 104.31% |
| 2023 FY | 122.78 Million USD | 1419.36% |
| 2023 Q1 | 2.15 Million USD | 62.79% |
| 2023 Q3 | 54.33 Million USD | 1135.25% |
| 2023 Q4 | 118.1 Million USD | 117.37% |
| 2022 Q2 | 6.53 Million USD | 0.0% |
| 2022 Q4 | 1.32 Million USD | 113.4% |
| 2022 FY | 8.08 Million USD | 562.24% |
| 2022 Q3 | 619.74 Thousand USD | -90.52% |
| 2021 Q2 | 4.85 Million USD | 0.0% |
| 2021 FY | -1.74 Million USD | -110.3% |
| 2021 Q4 | -6.67 Million USD | 0.0% |
| 2020 Q2 | 8.2 Million USD | 0.0% |
| 2020 FY | 16.97 Million USD | -78.19% |
| 2020 Q4 | 8.18 Million USD | 0.0% |
| 2019 FY | 77.83 Million USD | 142.39% |
| 2019 Q4 | 58.92 Million USD | 0.0% |
| 2019 Q2 | 18.78 Million USD | 0.0% |
| 2018 FY | 32.11 Million USD | 36.4% |
| 2017 FY | 23.54 Million USD | 25.72% |
| 2016 FY | 18.72 Million USD | 333.82% |
| 2015 FY | 4.31 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -162271.007% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -574.903% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -6264.069% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -679.521% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -697668.691% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -472.464% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -186964.601% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -1983.257% |
| Marizyme, Inc. | 645.81 Thousand USD | -18938.699% |
| Genus plc | 668.8 Million USD | 81.616% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | 49.879% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -124103.306% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -29876.673% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -160077.461% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -311033.714% |
| MultiCell Technologies, Inc. | 49.32 USD | -249297996.107% |
| ONE Bio Corp. | 52.29 Million USD | -135.11% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -147.288% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -251339.307% |
| Q BioMed Inc. | 284.35 Thousand USD | -43140.006% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -315.427% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 15.262% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -21946.193% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -175548.316% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -18571.803% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 99.163% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -12307589.79% |
| Enzolytics Inc. | 52.79 Thousand USD | -232784.728% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -20105.221% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 89.974% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -87572.609% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -19815.291% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 85.354% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -12223.406% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -154.278% |
| BioStem Technologies, Inc. | 16.68 Million USD | -636.894% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -51875.744% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -51875.744% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -8881.287% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -25854.409% |
| SYBLEU INC | 11.69 Thousand USD | -1051146.76% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -1478.557% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -945698.623% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -310907.793% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -3592.307% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -1744.769% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -11733.862% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -377.176% |
| CSL Limited | 14.8 Billion USD | 99.169% |
| Cellectis S.A. | 755 Thousand USD | -16185.274% |